2024 Partners

Antaros Medical

Expertise Partner

Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal & metabolic diseases and oncology.



Expertise Partner

OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research.



Expertise Partner

Perspectum is an innovative company pushing the frontier of personalized medicine through our advanced non-invasive imaging portfolio. Working across the obesity and metabolic disease space, our best-in-class precision health technology provides sponsors with tangible insights into the mechanisms and benefits of their incretin-based treatments. Working across the entire development pipeline, we support sponsors to differentiate their treatments by allowing them to see and quantify more than ever before.



Expertise Partner

Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US. Truveta is trusted by more than 50 leading healthcare and life science customers to study safety and effectiveness, improve patient care, and train medical AI. Across these leading organizations, Truveta connects data, people, and ideas to pursue a shared mission of Saving Lives with Data. 


Worldwide Clinical Trials

Hosting Partner

Worldwide Clinical Trials (Worldwide) is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications – from discovery to reality.

Anchored in our company’s scientific heritage, we are therapeutically focused on cardiovascular, metabolic, neuroscience, oncology, and rare diseases. Our deep therapeutic knowledge enables us to develop flexible plans and quickly solve problems for our customers.



Exhibition Partner

BioDuro-Sundia, a US-based Advent International CRDMO with 28 years of expertise, excels in contract research, development, and manufacturing. With a global team of 3,000 across 7 sites, we offer integrated services, specializing in GLP-1 capabilities, small and large molecule discovery, and bioavailability enhancement. Our one-stop-shop accelerates drug development, ensuring compliance with global standards. A science-driven, customer-oriented culture defines our commitment to providing top-tier, tailored services.


CPC Scientific

Exhibition Partner

Founded in 2001, CPC Scientific is a globally recognized and leading CDMO specializing in synthetic peptide and oligonucleotide production. We work directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. We boast the largest research peptide facility in the world, which successfully has undergone multiple FDA inspections and audits by global pharma organizations. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing. We provide milligram to multi-kilogram quantities of CGMP and research-grade peptides and oligonucleotides with purities of up to 99%. With our emphasis on technology, innovation, and quality, we are proud to have a US FDA inspected GMP facility, ISO 9001, and ISO 13485 certification, a claim few companies in the world can make.


Dandelion Health

Event Partner

Dandelion Health is a precision medicine platform. Dandelion offers the first and only real-world clinical dataset purpose-built to capture the underlying biology of cardiometabolic diseases, including the role of GLP-1s in treatment. Access petabytes of multimodal clinical data—imaging, waveforms, notes, pathology, and videos linked to long-term quantitative and qualitative outcomes in the EHR—to develop treatments, companion diagnostics, algorithms, or real-world evidence about GLP-1 use (on-label and exploratory) for a diverse U.S. patient population that may be excluded from insurance claims and clinical trials.



Event Partner

At Gubra we have extensive scientific expertise and capabilities to conduct preclinical studies using animal models of obesity. We conduct comprehensive efficacy and mode-of-action studies combining in vivo metabolic profiling with biomarker analysis, histology, whole-brain imaging and RNAseq to evaluate and visualize the effects of your drug candidate.


Want to See Your Logo Here in 2025?